These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 19642244

  • 1. Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this?
    Gupta SK.
    AIDS Read; 2009; 19(6):246. PubMed ID: 19642244
    [No Abstract] [Full Text] [Related]

  • 2. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
    Psevdos G, Gonzalez E, Sharp V.
    AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
    [Abstract] [Full Text] [Related]

  • 3. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
    Gupta Samir K.
    AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
    [No Abstract] [Full Text] [Related]

  • 4. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.
    Malik A, Abraham P, Malik N.
    J Infect; 2005 Aug; 51(2):E61-5. PubMed ID: 16038754
    [Abstract] [Full Text] [Related]

  • 5. Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.
    Atta MG, Fine DM.
    AIDS Read; 2009 Mar; 19(3):118-9. PubMed ID: 19334329
    [No Abstract] [Full Text] [Related]

  • 6. Meeting notes from ICAAC. Tenofovir + ddI: a combination to avoid.
    Sax PE.
    AIDS Clin Care; 2005 Jan; 17(1):6-7. PubMed ID: 15717372
    [No Abstract] [Full Text] [Related]

  • 7. Tenofovir and changes in renal function.
    Gupta SK.
    Clin Infect Dis; 2005 Aug 15; 41(4):570-1; author reply 571. PubMed ID: 16028175
    [No Abstract] [Full Text] [Related]

  • 8. Tenofovir and didanosine: a dangerous liaison.
    Waters L, Maitland D, Moyle GJ.
    AIDS Read; 2005 Aug 15; 15(8):403-6, 413. PubMed ID: 16110555
    [No Abstract] [Full Text] [Related]

  • 9. [First line therapy. Tenofovir DF/emtricitabine--the potent backbone].
    MMW Fortschr Med; 2008 Apr 28; 150 Spec No 1():12-4. PubMed ID: 19024908
    [No Abstract] [Full Text] [Related]

  • 10. Serum creatinine changes in HIV-seropositive patients receiving tenofovir.
    El Sahly HM, Teeter L, Zerai T, Andrade RA, Munoz C, Nnabuife C, Hunter R.
    AIDS; 2006 Mar 21; 20(5):786-7. PubMed ID: 16514316
    [No Abstract] [Full Text] [Related]

  • 11. CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related.
    Kakuda TN, Anderson PL, Becker SL.
    AIDS; 2004 Dec 03; 18(18):2442-4. PubMed ID: 15622326
    [No Abstract] [Full Text] [Related]

  • 12. Tenofovir-associated kidney diseases and interactions between tenofovir and other antiretrovirals.
    Lanzafame M, Lattuada E, Rapagna F, Gottardi M, Vento S.
    Clin Infect Dis; 2006 Jun 01; 42(11):1656-7; author reply 1658. PubMed ID: 16652329
    [No Abstract] [Full Text] [Related]

  • 13. Response to Blaas et al., 'Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases'.
    Ranneberg B, Mertenskoetter T, Pearce G.
    AIDS; 2007 Mar 30; 21(6):783. PubMed ID: 17413708
    [No Abstract] [Full Text] [Related]

  • 14. Tenofovir-induced acute renal failure in an HIV patient with normal renal function.
    Krummel T, Parvez-Braun L, Frantzen L, Lalanne H, Marcellin L, Hannedouche T, Moulin B.
    Nephrol Dial Transplant; 2005 Feb 30; 20(2):473-4. PubMed ID: 15673708
    [No Abstract] [Full Text] [Related]

  • 15. The role of drug interactions and monitoring in the prevention of tenofovir-associated kidney disease.
    Winston JA, Shepp DH.
    Clin Infect Dis; 2006 Jun 01; 42(11):1657-8; author reply 1658. PubMed ID: 16652330
    [No Abstract] [Full Text] [Related]

  • 16. Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients.
    Fabbiani M, Bracciale L, Doino M, D'Avino A, Marzocchetti A, Navarra P, Cauda R, De Luca A, Di Giambenedetto S.
    J Infect; 2011 Apr 01; 62(4):319-21. PubMed ID: 21329725
    [No Abstract] [Full Text] [Related]

  • 17. Renal safety of tenofovir disoproxil fumarate.
    Sax PE, Gallant JE, Klotman PE.
    AIDS Read; 2007 Feb 01; 17(2):90-2, 99-104, C3. PubMed ID: 17323508
    [Abstract] [Full Text] [Related]

  • 18. Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases.
    Blaas S, Schneidewind A, Glück T, Salzberger B.
    AIDS; 2006 Aug 22; 20(13):1786-7. PubMed ID: 16931948
    [No Abstract] [Full Text] [Related]

  • 19. Editorial comment: tenofovir nephrotoxicity--vigilance required.
    Fine DM.
    AIDS Read; 2005 Jul 22; 15(7):362-3. PubMed ID: 16044578
    [No Abstract] [Full Text] [Related]

  • 20. HIV therapy may be given safely in resource-limited settings without routine laboratory monitoring.
    AIDS Patient Care STDS; 2009 Aug 22; 23(8):680-1. PubMed ID: 19694040
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.